Legacy Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
1,039
-77
-7% -$21.3K 0.02% 303
2026
Q1
$330K Buy
1,116
+1
+0.1% +$297 0.04% 198
2025
Q4
$304K Buy
1,115
+137
+14% +$37.2K 0.03% 220
2025
Q3
$264K Buy
+978
New +$266K 0.03% 214
2025
Q2
Sell
-8,674
Closed -$2.3M 95
2025
Q1
$2.3M Buy
8,674
+1,117
+15% +$276K 0.24% 81
2024
Q4
$1.8M Buy
7,557
+3,341
+79% +$768K 0.17% 93
2024
Q3
$930K Buy
4,216
+1,320
+46% +$273K 0.1% 160
2024
Q2
$569K Buy
2,896
+597
+26% +$123K 0.07% 191
2024
Q1
$495K Buy
2,299
+372
+19% +$78.1K 0.06% 207
2023
Q4
$406K Sell
1,927
-71
-4% -$15.1K 0.05% 211
2023
Q3
$400K Buy
1,998
+42
+2% +$8.35K 0.06% 204
2023
Q2
$362K Buy
+1,956
New +$361K 0.05% 200
2019
Q3
Sell
-558
Closed -$108K 158
2019
Q2
$108K Hold
558
0.07% 157
2019
Q1
$92K Buy
+558
New +$98.6K 0.03% 162
2018
Q4
Sell
-558
Closed -$95K 176
2018
Q3
$95K Hold
558
0.05% 181
2018
Q2
$91K Hold
558
0.07% 141
2018
Q1
$91K Buy
+558
New +$88.8K 0.07% 121

Other funds holding CME

Legacy Advisors's CME Position: Q2 2026 in Review

Legacy Advisors reduced its CME Group (CME) stake by 6.9% in Q2 2026, selling an estimated $21.3K and leaving 1,039 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #303.

Legacy Advisors first reported a position in CME in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.3M in Q1 2025. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Legacy Advisors held 1,039 shares of CME Group worth $229K as of Q2 2026.
  • Legacy Advisors sold 77 CME Group shares in Q2 2026, an estimated $21.3K.
  • CME Group made up 0.02% of Legacy Advisors's portfolio in Q2 2026, its #303 holding.
  • Legacy Advisors first reported a position in CME Group in Q1 2018 and has held it in 17 quarters since.
  • Legacy Advisors's CME Group position peaked at $2.3M in Q1 2025.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.